Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 13.71% is in line with its 5-year average of 13.87%, around the middle of its 5-year range (12.31%–16.61%).
As of the fiscal period ended Sunday, December 28, 2025. 0.15% below its 12-month average of 13.73%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
13.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
13.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
14.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
13.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
12.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
14.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
15.22%
CURRENT VS TTM AVG
-0.15%
CURRENT VS 3Y AVG
-2.73%
CURRENT VS 5Y AVG
-1.18%
CURRENT VS 10Y AVG
+6.77%
CURRENT VS 15Y AVG
-2.65%
CURRENT VS 20Y AVG
-9.94%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+60.73%
vs the sector median at left
Johnson & Johnson
Market Cap
$639.47B
Return on Invested Capital (ROIC)
13.71%
TTM Avg
13.73%
3Y Avg
14.10%
5Y Avg
13.87%
Market Cap
$143.00B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
9.06%
3Y Avg
10.60%
5Y Avg
10.43%
Market Cap
$320.80B
Return on Invested Capital (ROIC)
18.27%
TTM Avg
18.62%
3Y Avg
14.12%
5Y Avg
12.73%
Market Cap
$465.28B
Return on Invested Capital (ROIC)
12.97%
TTM Avg
10.91%
3Y Avg
11.35%
5Y Avg
11.16%
Market Cap
$1.14T
Return on Invested Capital (ROIC)
30.20%
TTM Avg
28.28%
3Y Avg
24.95%
5Y Avg
23.04%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | $639.47B | 13.71% | 13.73% | 14.10% | 13.87% |
| Pfizer Inc. (PFE)vs › | $143.00B | 8.84% | 9.06% | 10.60% | 10.43% |
| Merck & Co., Inc. (MRK)vs › | $320.80B | 18.27% | 18.62% | 14.12% | 12.73% |
| AbbVie Inc. (ABBV)vs › | $465.28B | 12.97% | 10.91% | 11.35% | 11.16% |
| Eli Lilly and Company (LLY)vs › | $1.14T | 30.20% | 28.28% | 24.95% | 23.04% |
| Bristol-Myers Squibb Company (BMY)vs › | $129.53B | 13.90% | 13.75% | 11.92% | 10.17% |
ROIC
13.7%
ROE
24.8%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-28 | 13.71% |
| 2024-12-29 | 13.75% |
| 2023-12-31 | 16.61% |
| 2023-01-01 | 12.31% |
| 2022-01-02 | 13.83% |
| 2021-01-03 | 13.03% |
| 2019-12-31 | 14.88% |
| 2018-12-31 | 14.45% |
| 2017-12-31 | 1.06% |
| 2016-12-31 | 14.59% |
| 2015-12-31 | 13.03% |
| 2014-12-31 | 15.30% |
| 2013-12-31 | 15.15% |
| 2012-12-31 | 12.77% |
| 2011-12-31 | 12.96% |
| 2010-12-31 | 14.87% |
| 2009-12-31 | 16.37% |
| 2008-12-31 | 18.24% |
| 2007-12-31 | 19.05% |
| 2006-12-31 | 18.56% |
| 2005-12-31 | 20.99% |
| 2004-12-31 | 20.66% |
| 2003-12-31 | 21.11% |
| 2002-12-31 | 22.01% |
| 2001-12-31 | 18.25% |
| 2000-12-31 | 16.75% |
| 1999-12-31 | 18.51% |
| 1998-12-31 | 16.60% |
| 1997-12-31 | 19.76% |
| 1996-12-31 | 19.62% |
